Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16

摘要

Study question How did prescription opioid use change in the United States between 2007 and 2016 among people covered by commercial insurance (eg, insurance received through an employer) or by Medicare Advantage (eg, people aged 65 years and over and people with a long term disability)? Methods This study of administrative claims data used a database of medical and pharmacy claims for commercially insured and Medicare Advantage beneficiaries to trackthe opioid use of 48 million US individuals. Key endpoints were the proportion of beneficiaries with any opioid prescription per quarter and the average daily dose in milligram morphine equivalents (MME).